Founder, Chief Mission and Strategy Officer
Lazarex Cancer Foundation
Dana Dornsife is Chief Mission and Strategy Officer at Lazarex Cancer Foundation, a nationwide non-profit organization she founded in 2006. The unique mission of Lazarex is to improve cancer health outcomes, FDA cancer clinical trial diversity and enrolment, and patient access to care by providing assistance with clinical trial navigation, reimbursing trial related travel costs, and partnering with at-risk communities to mobilize resources.
In 2016, Dana expanded the mission at Lazarex to bring sustainable and transformational change to clinical trial enrolment, retention, minority participation and equitable access with IMPACT (IMproving Patient Access to Cancer Clinical Trials). Most recently, Lazarex created collaboration around a public health initiative, the Lazarex Cancer Wellness HUBs. This bold initiative is aimed at creating a replicable model to address cancer health disparities and improve cancer health outcomes. Dana is a graduate of Drexel University in Philadelphia, serves on several Boards, and participates in many philanthropic initiatives with her husband Dave Dornsife.